Shlomit Metula, Ph.D has extensive work experience in the field of scientific research. Shlomit currently serves as the Chief Scientific Officer at Soos Technology since July 2021. Prior to this, they worked as a Senior Scientist at PiNK Biopharma from February 2019 to July 2021. Additionally, they held the position of Senior Research Associate at Ben-Gurion University of the Negev from February 2010 to January 2018.
Shlomit Metula, Ph.D has a strong educational background in the field of science and medicine. Shlomit began their academic journey at the Albert Einstein College of Medicine, where they focused on Biochemistry and antibody discovery as a scholar scientist. After completing their studies there, they moved on to pursue a Doctor of Philosophy (Ph.D) in Oncology and Cancer Biology at Ben-Gurion University of the Negev. It is unclear whether they obtained any additional degree or field of study at the same institution.
July, 2021 - present
Acting Chief Scientific Officer at Dracen Pharmaceuticals
CEO & Chief Scientific Officer at FreMon Scientific
Chief Scientific Officer at Jubilant Radiopharma
CEO & Chief Scientific Officer at Kephera Diagnostics
EVP, Chief Scientific Officer at Mirati Therapeutics
Access the worlds's biggest network of public org charts
Learn more